Eli Lilly and Company
SODIUM-HYDROGEN EXCHANGER 3 INHIBITOR COMPOUNDS
Last updated:
Abstract:
The present invention relates to sodium-hydrogen exchanger 3 (NHE3) inhibitor compounds of the Formula: ##STR00001## to pharmaceutical compositions comprising the compound and to the use of the compound for the treatment of certain diseases associated with elevated sodium and/or phosphate levels.
Status:
Application
Type:
Utility
Filling date:
8 May 2020
Issue date:
7 Jul 2022